目次

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Number of Cancer Cases to Drive the Vaccine Demand
3.2.1.2 Rising investment by PPPs and Government to Boost the Market Growth
3.2.2 Market Restraining Factors
3.2.2.1 Challenges Posed by Stringent Regulatory Guidelines and Extended Timelines in the Manufacturing Process of Cancer Vaccines
3.2.2.2 Advancement in Personalised Medicine to Hamper the Market Growth
3.2.3 Market Opportunities
3.2.3.1 Increasing Organic and Inorganic Activities to Boost the Cancer Vaccines Market Growth
3.2.3.2 Adoption of Technology in Drug Development to Create Market Opportunities for Cancer Vaccines
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Cancer Vaccines Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Cancer Vaccines Market Size Estimation and Forecast by Type
4.4 Preventive Vaccines
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Therapeutic Vaccines
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Cancer Vaccines Market Analysis by Technology
5.1 Key Findings
5.2 Technology Segment: Market Attractiveness Index
5.3 Cancer Vaccines Market Size Estimation and Forecast by Technology
5.4 Dendritic Cells
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Recombinant
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Antigen/Adjuvant
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Viral Vector and DNA
5.7.1 Market Size by Region, 2023-2033 (US$ Million)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Whole-cell
5.8.1 Market Size by Region, 2023-2033 (US$ Million)
5.8.2 Market Share by Region, 2023 & 2033 (%)

6 Cancer Vaccines Market Analysis by Indications
6.1 Key Findings
6.2 Indications Segment: Market Attractiveness Index
6.3 Cancer Vaccines Market Size Estimation and Forecast by Indications
6.4 Cervical Cancer
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Prostate Cancer
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Other Indications
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)

7 Cancer Vaccines Market Analysis by End-users
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 Cancer Vaccines Market Size Estimation and Forecast by End-users
7.4 Paediatrics
7.4.1 Market Size by Region, 2023-2033 (US$ Million)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Adults
7.5.1 Market Size by Region, 2023-2033 (US$ Million)
7.5.2 Market Share by Region, 2023 & 2033 (%)

8 Cancer Vaccines Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Cancer Vaccines Market Analysis
9.1 Key Findings
9.2 North America Cancer Vaccines Market Attractiveness Index
9.3 North America Cancer Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 North America Cancer Vaccines Market Size Estimation and Forecast by Country
9.5 North America Cancer Vaccines Market Size Estimation and Forecast by Type
9.6 North America Cancer Vaccines Market Size Estimation and Forecast by Technology
9.7 North America Cancer Vaccines Market Size Estimation and Forecast by Indications
9.8 North America Cancer Vaccines Market Size Estimation and Forecast by End-users
9.9 U.S. Cancer Vaccines Market Analysis
9.10 Canada Cancer Vaccines Market Analysis

10 Europe Cancer Vaccines Market Analysis
10.1 Key Findings
10.2 Europe Cancer Vaccines Market Attractiveness Index
10.3 Europe Cancer Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Europe Cancer Vaccines Market Size Estimation and Forecast by Country
10.5 Europe Cancer Vaccines Market Size Estimation and Forecast by Type
10.6 Europe Cancer Vaccines Market Size Estimation and Forecast by Technology
10.7 Europe Cancer Vaccines Market Size Estimation and Forecast by Indications
10.8 Europe Cancer Vaccines Market Size Estimation and Forecast by End-users
10.9 Germany Cancer Vaccines Market Analysis
10.10 France Cancer Vaccines Market Analysis
10.11 UK Cancer Vaccines Market Analysis
10.12 Italy Cancer Vaccines Market Analysis
10.13 Spain Cancer Vaccines Market Analysis
10.14 Russia Cancer Vaccines Market Analysis
10.15 Rest of Europe Cancer Vaccines Market Analysis

11 Asia Pacific Cancer Vaccines Market Analysis
11.1 Key Findings
11.2 Asia Pacific Cancer Vaccines Market Attractiveness Index
11.3 Asia Pacific Cancer Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Asia Pacific Cancer Vaccines Market Size Estimation and Forecast by Country
11.5 Asia Pacific Cancer Vaccines Market Size Estimation and Forecast by Type
11.6 Asia Pacific Cancer Vaccines Market Size Estimation and Forecast by Technology
11.7 Asia Pacific Cancer Vaccines Market Size Estimation and Forecast by Indications
11.8 Asia Pacific Cancer Vaccines Market Size Estimation and Forecast by End-users
11.9 Japan Cancer Vaccines Market Analysis
11.10 China Cancer Vaccines Market Analysis
11.11 India Cancer Vaccines Market Analysis
11.12 Australia Cancer Vaccines Market Analysis
11.13 South Korea Cancer Vaccines Market Analysis
11.14 Rest of Asia Pacific Cancer Vaccines Market Analysis

12 Latin America Cancer Vaccines Market Analysis
12.1 Key Findings
12.2 Latin America Cancer Vaccines Market Attractiveness Index
12.3 Latin America Cancer Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Latin America Cancer Vaccines Market Size Estimation and Forecast by Country
12.5 Latin America Cancer Vaccines Market Size Estimation and Forecast by Type
12.6 Latin America Cancer Vaccines Market Size Estimation and Forecast by Technology
12.7 Latin America Cancer Vaccines Market Size Estimation and Forecast by Indications
12.8 Latin America Cancer Vaccines Market Size Estimation and Forecast by End-users
12.9 Brazil Cancer Vaccines Market Analysis
12.10Mexico Cancer Vaccines Market Analysis
12.11Rest of Latin America Cancer Vaccines Market Analysis

13 MEA Cancer Vaccines Market Analysis
13.1 Key Findings
13.2 MEA Cancer Vaccines Market Attractiveness Index
13.3 MEA Cancer Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 MEA Cancer Vaccines Market Size Estimation and Forecast by Country
13.5 MEA Cancer Vaccines Market Size Estimation and Forecast by Type
13.6 MEA Cancer Vaccines Market Size Estimation and Forecast by Technology
13.7 MEA Cancer Vaccines Market Size Estimation and Forecast by Indications
13.8 MEA Cancer Vaccines Market Size Estimation and Forecast by End-users
13.9 GCC Cancer Vaccines Market Analysis
13.10 South Africa Cancer Vaccines Market Analysis
13.11 Rest of MEA Cancer Vaccines Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Strategic Outlook
14.3 GSK plc
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2022
14.3.3.2 R&D, 2017-2022
14.3.3.3 Regional Market Shares, 2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Merck & Co., Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2022
14.4.3.2 R&D, 2017-2022
14.4.3.3 Regional Market Shares, 2022
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Amgen Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2022
14.5.3.2 R&D, 2017-2022
14.5.3.3 Regional Market Shares, 2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Walvax Biotechnology Co. Ltd.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2018-2022
14.6.3.2 R&D, 2018-2022
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 OSE Immunotherapeutics
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2018-2022
14.7.3.2 R&D, 2017-2022
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Synthaverse S. A. (Biomed-Lublin)
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.9 Dendreon Pharmaceuticals LLC
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.9.4 Strategic Outlook
14.10 F. Hoffmann-La Roche Ltd
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2018-2022
14.10.3.2 R&D, 2017-2022
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Moderna, Inc.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2017-2022
14.11.3.2 R&D, 2017-2022
14.11.3.3 Regional Market Shares, 2022
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 AstraZeneca
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2017-2022
14.12.3.2 R&D, 2017-2022
14.12.3.3 Regional Market Shares, 2022
14.12.4 Product Benchmarking

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Cancer Vaccines Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Cancer Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Cancer Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Cancer Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Cancer Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 7 Preventive Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 8 Therapeutic Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Dendritic Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Recombinant Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Antigen/Adjuvant Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Viral Vector and DNA Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Whole-cell Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Cervical Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Prostate Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Other Indications Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Paediatrics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Adults Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Cancer Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 North America Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 North America Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 North America Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 North America Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 North America Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 U.S. Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Canada Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Europe Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 31 Europe Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Europe Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 33 Europe Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Europe Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Germany Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 France Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 UK Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Italy Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Spain Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Russia Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Rest of Europe Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Asia Pacific Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Asia Pacific Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Asia Pacific Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Asia Pacific Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Asia Pacific Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Japan Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 China Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 India Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Australia Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 South Korea Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Rest of Asia Pacific Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 53 Latin America Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Latin America Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Latin America Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Latin America Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Latin America Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Brazil Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Mexico Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Rest of Latin America Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 MEA Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 MEA Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 MEA Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 MEA Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 MEA Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 GCC Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 South Africa Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Rest of MEA Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 69 Strategic Outlook
Table 70 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 GSK Plc: Product Benchmarking
Table 72 GSK Plc: Strategic Outlook
Table 73 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Merck & Co., Inc.: Product Benchmarking
Table 75 Merck & Co., Inc.: Strategic Outlook
Table 76 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Amgen Inc.: Product Benchmarking
Table 78 Amgen Inc.: Strategic Outlook
Table 79 Walvax Biotechnology Co. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Walvax Biotechnology Co. Ltd.: Product Benchmarking
Table 81 Walvax Biotechnology Co. Ltd.: Strategic Outlook
Table 82 OSE Immunotherapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 OSE Immunotherapeutic: Product Benchmarking
Table 84 OSE Immunotherapeutic: Strategic Outlook
Table 85 Synthaverse S. A. (Biomed-Lublin): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Synthaverse S. A. (Biomed-Lublin): Product Benchmarking
Table 87 Dendreon Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Dendreon Pharmaceuticals LLC: Product Benchmarking
Table 89 Dendreon Pharmaceuticals LLC: Strategic Outlook
Table 90 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 92 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 93 Moderna, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Moderna, Inc.: Product Benchmarking
Table 95 Moderna, Inc.: Strategic Outlook
Table 96 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 AstraZeneca: Product Benchmarking

List of Figures
Figure 1 Cancer Vaccines Market Segmentation
Figure 2 Cancer Vaccines Market by Type: Market Attractiveness Index
Figure 3 Cancer Vaccines Market by Technology: Market Attractiveness Index
Figure 4 Cancer Vaccines Market by Indications: Market Attractiveness Index
Figure 5 Cancer Vaccines Market by End-users: Market Attractiveness Index
Figure 6 Cancer Vaccines Market Attractiveness Index by Region
Figure 7 Cancer Vaccines Market Dynamics
Figure 8 Global Cancer Case Rate per 100,000 People, 2015-2020
Figure 9 Global Cancer Cases by Country, 2022
Figure 10 R&D Spending by Major Oncology Companies, 2018-2022
Figure 11 Cancer Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 12 Cancer Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 13 Cancer Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 14 Cancer Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 15 Cancer Vaccines Market: Porter’s Five Forces Analysis
Figure 16 Cancer Vaccines Market: PEST Analysis
Figure 17 Cancer Vaccines Market by Type: Market Attractiveness Index
Figure 18 Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 19 Cancer Vaccines Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 20 Preventive Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 21 Preventive Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 Therapeutic Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 23 Therapeutic Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Cancer Vaccines Market by Technology: Market Attractiveness Index
Figure 25 Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 26 Cancer Vaccines Market Share Forecast by Technology, 2023, 2028, 2033 (%)
Figure 27 Dendritic Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Dendritic Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Recombinant Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 30 Recombinant Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Antigen/Adjuvant Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 32 Antigen/Adjuvant Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Viral Vector and DNA Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 34 Viral Vector and DNA Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Whole-cell Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 36 Whole-cell Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Cancer Vaccines Market by Indications: Market Attractiveness Index
Figure 38 Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR %)
Figure 39 Cancer Vaccines Market Share Forecast by Indications, 2023, 2028, 2033 (%)
Figure 40 Cervical Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 41 Cervical Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Prostate Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 43 Prostate Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 44 Other Indications Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 45 Other Indications Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 46 Cancer Vaccines Market by End-users: Market Attractiveness Index
Figure 47 Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 48 Cancer Vaccines Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 49 Paediatrics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Paediatrics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Adults Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 52 Adults Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Cancer Vaccines Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 54 Cancer Vaccines Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 55 Cancer Vaccines Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 56 North America Cancer Vaccines Market Attractiveness Index
Figure 57 North America Cancer Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 58 North America Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 59 North America Cancer Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 60 North America Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 61 North America Cancer Vaccines Market Share Forecast by Type, 2023 & 2033 (%)
Figure 62 North America Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 63 North America Cancer Vaccines Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 64 North America Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR %)
Figure 65 North America Cancer Vaccines Market Share Forecast by Indications, 2023 & 2033 (%)
Figure 66 North America Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 67 North America Cancer Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 68 U.S. Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 Canada Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 70 Europe Cancer Vaccines Market Attractiveness Index
Figure 71 Europe Cancer Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 72 Europe Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 73 Europe Cancer Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 74 Europe Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 75 Europe Cancer Vaccines Market Share Forecast by Type, 2023 & 2033 (%)
Figure 76 Europe Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 77 Europe Cancer Vaccines Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 78 Europe Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR %)
Figure 79 Europe Cancer Vaccines Market Share Forecast by Indications, 2023 & 2033 (%)
Figure 80 Europe Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 81 Europe Cancer Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 82 Germany Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 83 France Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 84 UK Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 85 Italy Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 Spain Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 Russia Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Rest of Europe Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 Asia Pacific Cancer Vaccines Market Attractiveness Index
Figure 90 Asia Pacific Cancer Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 91 Asia Pacific Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 92 Asia Pacific Cancer Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 93 Asia Pacific Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 94 Asia Pacific Cancer Vaccines Market Share Forecast by Type, 2023 & 2033 (%)
Figure 95 Asia Pacific Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 96 Asia Pacific Cancer Vaccines Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 97 Asia Pacific Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR %)
Figure 98 Asia Pacific Cancer Vaccines Market Share Forecast by Indications, 2023 & 2033 (%)
Figure 99 Asia Pacific Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 100 Asia Pacific Cancer Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 101 Japan Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 China Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 103 India Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 Australia Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 105 South Korea Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 Rest of Asia Pacific Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Latin America Cancer Vaccines Market Attractiveness Index
Figure 108 Latin America Cancer Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 109 Latin America Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 110 Latin America Cancer Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 111 Latin America Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 112 Latin America Cancer Vaccines Market Share Forecast by Type, 2023 & 2033 (%)
Figure 113 Latin America Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 114 Latin America Cancer Vaccines Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 115 Latin America Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR %)
Figure 116 Latin America Cancer Vaccines Market Share Forecast by Indications, 2023 & 2033 (%)
Figure 117 Latin America Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 118 Latin America Cancer Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 119 Brazil Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 120 Mexico Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 Rest of Latin America Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 122 MEA Cancer Vaccines Market Attractiveness Index
Figure 123 MEA Cancer Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 124 MEA Cancer Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 125 MEA Cancer Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 126 MEA Cancer Vaccines Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 127 MEA Cancer Vaccines Market Share Forecast by Type, 2023 & 2033 (%)
Figure 128 MEA Cancer Vaccines Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
Figure 129 MEA Cancer Vaccines Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 130 MEA Cancer Vaccines Market Forecast by Indications, 2023-2033 (US$ Million, AGR %)
Figure 131 MEA Cancer Vaccines Market Share Forecast by Indications, 2023 & 2033 (%)
Figure 132 MEA Cancer Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 133 MEA Cancer Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 134 GCC Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 135 South Africa Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 136 Rest of MEA Cancer Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 137 GSK PLC: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 138 GSK PLC: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 139 GSK Plc: Regional Market Shares, 2022
Figure 140 Merck & Co., Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 141 Merck & Co., Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 142 Merck & Co., Inc.: Regional Market Shares, 2022
Figure 143 Amgen Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 144 Amgen Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 145 Amgen Inc.: Regional Market Shares, 2022
Figure 146 Walvax Biotechnology Co. Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 147 Walvax Biotechnology Co. Ltd.: R&D, 2018-2022 (US$ Million, AGR%)
Figure 148 OSE Immunotherapeutics: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 149 OSE Immunotherapeutics: R&D, 2017-2022 (US$ Million, AGR%)
Figure 150 F. Hoffmann-La Roche Ltd: Net Revenue, 2018-2022 (US$ Billion, AGR%)
Figure 151 F. Hoffmann-La Roche Ltd: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 152 Moderna, Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 153 Moderna, Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 154 Moderna, Inc.: Regional Market Shares, 2022
Figure 155 AstraZeneca: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 156 AstraZeneca: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 157 AstraZeneca: Regional Market Shares, 2022